Maintenance of antipsychotic efficacy with Amisulpride: Results of a long-term study versus haloperidol

Colonna, L; Rein, W.; Turjanski, S.

doi:10.1016/s0924-9338(99)80628-2

Cited by 2 publications

(5 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…47 A further report of Colonna 1998 48,49 was found 50 which contained some additional information. Appendix 2 contains the data extraction sheets for these trials.…”

Section: Numbers and Characteristics Of Included Rcts New Rctsmentioning

confidence: 99%

“…The original review included 15 studies: Boyer 1995, 51 Martinot 1995, 52 Delcker 1990, 53 Hillert 1994, 54 Turjanski 1998 (1), 55 Turjanski 1998 (2), 55 Puech 1998, 56 Moeller 1997, 57 Klein 1985, 58 Colonna 1998, 48,49 Speller 1997, 59 Danion 1998, 60 Boyer 1990, 61 Fleurot 1997, 62 Loo 1997. 63 Appendix 3 contains the data extraction sheets for these studies.…”

Section: Old Rctsmentioning

confidence: 99%

“…At least nine trials (Colonna 1998, 64 Danion 1998, 60 Loo 1997, 63 Moeller 1997, 65 Martinot 1995, 52 Puech 1998, 56 Speller 1997, 59 Fleurot 1997, 62 Carriere 2000 47 ) were carried out or sponsored by Synthelabo, the manufacturers of amisulpride. Nine studies were published only as conference abstracts (including the amisulpride versus risperidone and olanzapine studies) and many methodological details are missing from these reports.…”

Section: Total Rctsmentioning

confidence: 99%

“…Two trials (Danion 1998, 60 Carriere 2000 47 ) were of medium duration -3-4 months, two trials lasted for 6 months (Lecrubier 1999, 42 Lecrubier 2000 43 ), with the remaining three trials (Colonna 1998, 49 Loo 1997, 63 Speller 1997 59 ) being of 1 year's duration (Loo 1997 was run initially for 6 months with 141 participants, then extended to 12 months for those patients who responded to treatment).…”

Section: Duration Of Studiesmentioning

confidence: 99%

“…After some discussion it was decided to include these two studies in the review provisionally. Of the 22 studies, 20 were reported as double-blind, the other two (Boyer 1990, 61 Colonna 1998 [48][49][50] ) being of open randomised design. Blinding of patients and staff to treatment allocation was described in only one study and blinding of outcome assessments was described in none.…”

Section: Quality Of Included Studiesmentioning

confidence: 99%

See 4 more Smart Citations

A systematic review of atypical antipsychotic drugs in schizophrenia

Bagnall

Jones

Ginnelly

et al. 2003

Health Technol Assess

151

114

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. Contact Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTAA systematic review of atypical antipsychotic drugs in schizophrenia NHS R&D HTA ProgrammeT he NHS R&D Health Technology Assessment (HTA) Programme was set up in 1993 to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS.The research reported in this monograph was commissioned by the HTA Programme on behalf of the National Institute for Clinical Excellence (NICE). Technology assessment reports are completed in a limited time to inform the appraisal and guidance development processes managed by NICE. The review brings together evidence on key aspects of the use of the technology concerned. However, appraisals and guidance produced by NICE are informed by a wide range of sources.The research reported in this monograph was funded as project number 00/20/01.The views expressed in this publication are those of the authors and not necessarily those of the HTA Programme, NICE or the Department of Health. The editors wish to emphasise that funding and publication of this research by the NHS should not be taken as implicit support for any recommendations made by the authors. Criteria for inclusion in the HTA monograph seriesReports are published in the HTA monograph series if (1) they have resulted from work commissioned for the HTA Programme, and (2) they are of a sufficiently high scientific quality as assessed by the referees and editors.Reviews in Health Technology Assessment are termed 'syst...

show abstract

“…47 A further report of Colonna 1998 48,49 was found 50 which contained some additional information. Appendix 2 contains the data extraction sheets for these trials.…”

Section: Numbers and Characteristics Of Included Rcts New Rctsmentioning

confidence: 99%

Section: Old Rctsmentioning

confidence: 99%

Section: Total Rctsmentioning

confidence: 99%

Section: Duration Of Studiesmentioning

confidence: 99%

Section: Quality Of Included Studiesmentioning

confidence: 99%

See 3 more Smart Citations

A systematic review of atypical antipsychotic drugs in schizophrenia

Bagnall

Jones

Ginnelly

et al. 2003

Health Technol Assess

151

114

View full text Add to dashboard Cite

show abstract

Amisulpride for schizophrenia

Neto

Soares

Lima

2002

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

BackgroundThe treatment of schizophrenia with old, 'typical' antipsychotic drugs such as haloperidol can be problematic, because many people treated with these drugs will su er from movement disorders. Amisulpride is said to be an "atypical" antipsychotic which induces less movement disorder and which is e ective for the negative symptoms of schizophrenia. ObjectivesTo evaluate the e ects of amisulpride as compared with placebo, typical and atypical antipsychotic drugs for schizophrenia.

show abstract

Maintenance of antipsychotic efficacy with Amisulpride: Results of a long-term study versus haloperidol

Cited by 2 publications

References 0 publications

A systematic review of atypical antipsychotic drugs in schizophrenia

A systematic review of atypical antipsychotic drugs in schizophrenia

Amisulpride for schizophrenia

Contact Info

Product

Resources

About